Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
THE BEST BLACK FRIDAY DEAL YET (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NYSE:CO

Global Cord Blood - CO Stock Forecast, Price & News

$2.99
+0.77 (+34.68%)
(As of 09/23/2022)
Add
Compare
Today's Range
$2.21
$3.32
50-Day Range
$2.22
$2.99
52-Week Range
$2.03
$5.50
Volume
9.28 million shs
Average Volume
216,519 shs
Market Capitalization
$363.44 million
P/E Ratio
4.67
Dividend Yield
N/A
Price Target
N/A
CO stock logo

About Global Cord Blood (NYSE:CO) Stock

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Stock News Headlines

StockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)
See More Headlines
Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Company Calendar

Last Earnings
6/26/2018
Today
11/28/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
1,202
Year Founded
N/A

Profitability

Net Income
$79.04 million
Pretax Margin
50.50%

Debt

Sales & Book Value

Annual Sales
$196.12 million
Cash Flow
$0.71 per share
Book Value
$6.34 per share

Miscellaneous

Free Float
N/A
Market Cap
$363.44 million
Optionable
Optionable
Beta
-0.04

Key Executives

  • Ms. Ting Zheng (Age 50)
    CEO & CEO of Beijing Division
    Comp: $516.68k
  • Mr. Bing Chuen Chen (Age 46)
    Chief Financial Officer
    Comp: $516.68k
  • Ms. Xin Xu (Age 68)
    Chief Technology Officer
    Comp: $122.78k
  • Ms. Rui Arashiyama (Age 63)
    Chief Exec. Officer of Guangdong & Zhejiang Divisions
    Comp: $257.5k
  • Ms. Cathy Bai
    VP of Corp. Fin.













CO Stock - Frequently Asked Questions

How have CO shares performed in 2022?

Global Cord Blood's stock was trading at $4.19 at the beginning of 2022. Since then, CO stock has decreased by 28.7% and is now trading at $2.9876.
View the best growth stocks for 2022 here
.

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) announced its earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter. Global Cord Blood had a net margin of 40.29% and a trailing twelve-month return on equity of 10.63%.

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL).

What is Global Cord Blood's stock symbol?

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

Who are Global Cord Blood's major shareholders?

Global Cord Blood's stock is owned by many different institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (1.93%), BlueCrest Capital Management Ltd (0.62%), Benjamin F. Edwards & Company Inc. (0.05%), Marshall Wace LLP (0.01%), Simplex Trading LLC (0.00%) and Group One Trading L.P. (0.00%).
View institutional ownership trends
.

How do I buy shares of Global Cord Blood?

Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $2.99.

How much money does Global Cord Blood make?

Global Cord Blood (NYSE:CO) has a market capitalization of $363.14 million and generates $196.12 million in revenue each year. The medical research company earns $79.04 million in net income (profit) each year or $0.64 on an earnings per share basis.

How many employees does Global Cord Blood have?

The company employs 1,202 workers across the globe.

How can I contact Global Cord Blood?

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The official website for the company is www.globalcordbloodcorp.com. The medical research company can be reached via phone at (523) 605-8180, via email at ir@globalcordbloodcorp.com, or via fax at 852-3605-8181.

This page (NYSE:CO) was last updated on 11/28/2022 by MarketBeat.com Staff